AlleleNews -- for in between experiments
Click "Links" to find Product Group Pages on Allele Biotech home
Saturday, 01.20.2018, 01:40pm (GMT-7)
  Home
  Events
  FAQ
  RSS
  Links
  Site Map
  Contact
 
GET TO KNOW YOUR NEIGHBOR ; SDEE 2015 Year End Social on Dec 8th in San Diego ; Must Attend 5-Day Event in San Diego Starting Tomorrow! -- CDW on Cells, Sensors, and Sysems, with Updates on Stem Cells ; SDEE October 2015 Event - Financings: Tales from the Tranches ; Allele Biotech Takes Major Step into Nano Antibody Leadership Position
::| Keyword:       [Advance Search]
 
All News  
  All science fields
  News Release from Allele and Associated Organizations
  Using single cell technologies for functional studies
  Job Postings/Lab Visits/Vendor Shows
  Imaging, Structure, and Optogenetics
  Brain and Neuron Development
  Camelid Antibodies
  FP Technologies and In Vivo Imaging
  iPSC MSC ESC Differentiation
  Immune systems, T cell Therapy, stem cell therapy
  RNA, RNAi, and miRNA Updates
  NexGen Sequencing, Epigenetics, and Editing
  News Release from Other Organizations
  ::| Poll
How do you social? Pick your TOP (#1) pick!
Facebook
Twitter
GooglePlus
WeChat
LinkedIn
Myspace
Youtube
 
  ::| Newsletter
Your Name:
Your Email:
 
 
 
Job Postings/Lab Visits/Vendor Shows
 
Allele Sponsors SABPA Event at UCSD on March 23rd
Tuesday, 04.02.2013, 09:35am (GMT-7)

On March 23rd, 2013, SABPA held its eleventh Science & Technology forum. The forum attracted more than 370 registered attendees locally and internationally, which is a new record for the Science & Technology forum. This forum offers great opportunities to increase awareness of new technologies in developing novel biologic therapeutics and current trends on biologics discovery and development in academia and the pharma/biotech industry.

 

The morning session began with a talk by Dr. Peter Schultz, professor of Chemistry at Scripps Research Institute, and director of the newly founded California Institute for Biomedical Research (Calibr). Dr. Schultz introduced his lab's endeavor in expanding genetic codes for amino acids to introduce unnatural amino acids into proteins. They generated unique genetic codons coupled with tRNAs that recognize these codons and corresponding aminoacyl-tRNA synthetases that can attach unique amino acids to the tRNAs. Dr. Schultz showed that this methodology could efficiently incorporate a variety of artificial amino acids into proteins to generate proteins with desired functionalities. These artificially designed amino acids can serve special purposes such as NMR probes, fluorophores, amino acids with special chemical properties and post-translational modifications. He gave numerous examples on how these genetically coded unnatural amino acids could improve antibody-drug conjugates (ADCs) efficiency, accelerate vaccine design, enable the generation of a whole new class of antibodies with genetically encoded warheads etc. Dr. Schultz believes that expanding the genetic code can allow invention of new therapeutics and new tools for biology.

 

Dr. Thomas Bumol, vice president of Biotechnology and Autoimmunity, Lilly Research Labs, Lilly Biotechnology Center in San Diego, followed up Dr. Schultz's talk by first highlighting the significance of biologics to the pharmaceutical industry. In 2012, for the first time, the top selling drug in the world is a biologics drug (Humira). In addition, 4 of the top 5 selling drugs are biologics. Dr. Bumol then introduced Lilly's strategic shift to transform from a traditional pharmaceutical company focusing on small molecule drugs to a biopharmaceutical company with biological therapies representing half of the clinical pipelines. He believes that a lot of opportunities exist for protein-based therapeutics. Dr. Bumol further illustrated Lilly's protein engineering platform. By exchanging any amino acid with variable amino acids throughout a protein sequence, Lilly is able to generate biologic therapeutics with improved efficacy, safety, drug-like profile and convenient delivery. Dr. Bumol gave an example of Ixekizumab, a monoclonal antibody (mAb) against IL-17A developed by Lilly. It has shown great promise in treating Psoriasis patients. Lilly is determined to build world-class discovery, engineering and development capabilities for therapeutic mAbs.

 

The third speaker, Dr. David King, CSO of AnaptysBio, Inc, presented an innovative way of "Generating Improved Antibody Therapeutics through Somatic Hypermutation (SHM)

in vitro". SHM is a natural mechanism used by the human immune system, specifically B cells, to generate almost limitless antibodies against a variety of infectious agents using a limited set of genes within our genomes. AnaptysBio is the first company to successfully replicate SHM in vitro and develop the SHM-XEL™ platform

by combining SHM with a mammalian antibody display system and FACS based sorting system. This technology can be used to improve existing antibodies, discover novel antibodies, perform antibody humanization, and generate antibodies with multiple antigen specificity. Dr. King then gave examples highlighting the power of the SHM-XEL

™ platform. ANB004 is a highly potent human antibody discovered and optimized using AnaptysBio's SHM-XEL™ technology. Pre-clinical studies demonstrate that ANB004 effectively neutralizes IL-17A. With excellent biophysical properties, ANB004 will be a strong competitor against other IL-17A antagonists, such as Ixekizumab from Lilly. 

 

Jeremy Barton, vice president of Biotherapeutics Development at Pfizer gave his perspective on the progress of Antibody Drug Conjugates (ADCs). Dr. Barton described the technology of ADCs, which harness the targeting power of antibodies with the great efficacy of cytotoxics. In substantial details, he reviewed the history of ADC development, described the current status and the active research areas of ADC development in the pharmaceutical industry. Dr. Barton noted that ADCs have shown great promise with the success of ADCETRIS® against relapsed refractory Hodgkins Disease and trastuzumab DM1 for metastatic breast cancer. However, the success of these two drugs may not be representative of ADC as a whole class. The off-target toxicity of ADCs remains a big concern. Choose the best combination of site-specific conjugation/linker/payload in ADC design and the use of companion diagnostics will be essential to maximize ADC success.

 

The next speaker is Dr. Henry Ji, CEO and president of Sorrento Therapeutics. He introduced the core technology platforms of the company: the G-MAB library platform and the antibody formulated drug conjugate (AfDC). The G-MAB library has the industry leading antibody diversity. The AfDC technology allows the conjugation of a formulated drug to any antibody. The formulation can include multiple drugs in the capsule. He also introduced Cynviloq, a nanoparticle durg paclitaxel formulation. It has shown great promise in solubilizing paclitaxel.

 

The following panel discussion is lead by Steve Prestrlski, CEO of Xeris Pharmaceutics, with active discussion from panelists representing a diverse field, including Bhawanjit Brar, senior director of Zensun, Jeremy Barton from Pfizer, Brenden Gingrich, Partner from Knobble Martens, Jean Liu, VP from Halozyme Therapeutics, and Tim Tian, Senior Scientist from Laureate BioPharma. The moderator opened the discussion with a comment that biologics development is highly risky due to high cost, long developmental cycle, heavy regulation and increasing international division of labor. He then asked the panelists to discuss how to manage various major risks in biologics development and production. Dr. Gingrich discussed how to manage intellectual property risk from early drug development to late stage marketing. While Dr. Brar, a scientist trained in both UK and US, working in a Chinese drug company and research product for US market, talked about some of her experience on risk management in meeting cGMP standards by manufactures in Australia and China. Other panelists also contributed to the discussion from their unique perspective.

 

In the afternoon, several SABPA sponsors including MEIRxRS, Laureate BioPharma Inc., and Effinity Tech, Inc. hosted showcase presentations to targeted audience.

 

SABPA would like to thank all the speakers, sponsors and volunteers who made this event an outstanding success.

 

SABPA would also like to thank our media partners who reported the Science & Technology Forum in Chinese. http://www.sandiegochinesepress.com/press/?p=79386

http://scholarsupdate.zhongwenlink.com/news.asp?NewsID=10869


Comments (0)        Print        Tell friend        Top


Related Articles:
» Laboratory, Research/ Development
» Identification of active transcriptional regulatory elements from GRO-seq data
» Focus on epilepsy
» Technology Transfer for Startups--How to maximize value by working with the tech transfer office
» All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins
» Writing an NIH/SBIR Grant Intensive Workshop for Entrepreneurs--Thursday, July 10, 2014, 5:30pm – 8:30pm
» MDA5 and autoimmune disease
» Time-lapse X-ray phase-contrast microtomography for in vivo imaging and analysis of morphogenesis
» SDEE Co-Sponsoring Janssen Labs Event Dec 17–Trends in Financing
» [Report] Observing the Dynamics of Dipole-Mediated Energy Transport by Interaction Enhanced Imaging
» Building San Diego Biotech Event October 28 2013: Incubate, Communicate, Collaborate
» SABPA Event Tomorrow: Paving the Path to Success
» Biotech Employment Skills Training 2013 San Diego
» Proteomics: marked for depth
» Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells
» Phase modulation at the few-photon level for weak-nonlinearity-based quantum computing
» Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury
» Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts
» Manipulation of cellular light from green fluorescent protein by a femtosecond laser
» How does p53 control cellular response to stress in different ways?
» Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
» A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
» RNAi patent win
» Urocortin 3 as marker for mature beta cells
» Spatiotemporal control of gene expression by a light-switchable transgene system
» GPR-120 is a faulty fat sensor, as shown in mouse model and confirmed in human sequencing data
» Changes in stem cells--a comprehensive analysis
» Weight regain after weight loss linked to special alleles
» An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells
» Localization imaging with standard fluorescent proteins on live cells—Bayesian modeling
» On-chip optical isolation in monolithically integrated non-reciprocal optical resonators
» An Activating Mutation of AKT2 and Human Hypoglycemia
» Super-resolution 3D microscopy of live whole cells using structured illumination
» How to get NIH/SBIR Grants Intensive Workshop for Entrepreneurs
» Starting and Supporting a Business with Grants
» Epigenetic Licensing of Germline Gene Expression by Maternal RNA in C. elegans
» Looking at pathway, not just SNPs
» Functional mapping of single spines in cortical neurons in vivo
» New from Yamanaka lab: "Master transcription factor" Glis1 promotes reprogramming
» Identification of clustering artifacts in photoactivated localization microscopy
» Whole-genome sequencing identifies recurrent mutations in chronic lymphocyticleukaemia
» SDEE Quarterly Event: Serial Entrepreneurship--Success and Failure
» Human neurons can be directly generated from somatic cells.
» Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells
» A roadmap to generate renewable protein binders to the human proteome
» Fast, three-dimensional super-resolution imaging of live cells
» See Allele's Sales Managers for Deals at Scripps Tuesday 05/10
» Designing the Next Generation of Chemical Separation Membranes
» How the core RNAi pathway is regulated throughout the cell cycle
» Next-generation sequencing to generate interactome datasets
» Focus on stem cells
» 5/7/2011 (Sat): Japan Earthquake Relief Garage Sale (a charity rummage sale)
» Chemically defined conditions for human iPSC derivation and culture
» Cheap fluorescent microscope for M. tuberculosis detection
» A natural antagonist of TNFa with implications in treating arthritis
» Considerations for Qualifying a CMO to Manufacture your [Biologic] Product for FIH
» A bioinformatic assay for pluripotency in human cells by Müller et al.
» Mapping of signaling networks through synthetic genetic interaction analysis by RNAi
» Confined activation and subdiffractive localization enables whole-cell PALM with genetically expressed probes
» Drosophila Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression patterns
» Something new under the skin
» Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
» A microprobe for parallel optical and electrical recordings from single neurons in vivo
» Warming up to a glow
» Use of Light-Activated Cation Channel Channelrhodopsin-2 to Study Heart Pace Maker Cells
» Cost Effective Antibiotic Honey Screening – A ‘Sweet Investment’
» Scientists have found more than 30 new gene variations linked to obesity
» Hormone profiling from Randox provides quality results
» The long road: peering into live cells (some with photoswitchable FPs)
» Liquid ready to use controls ideal for Point-of-Care (POC) testing
» SDEE Oct 13th Event: Intellectual Property and Licensing
» Improved patient profiling with Randox Metabolic Syndrome Arrays
» House's Appropriations Committee’s health spending subcommittee's 2011 NIH NSF budgets
» MicroRNA-132 is identified as a stimulator of neovascularization
» Hello SDSU
» GFP-Trap Successfully Used in Plants and Other Systems
» Witness the launch of Evidence Evolution at AACC
» Fruitless chirping in the night
» Whole mouse organs imaged in 3D Using Self Fluorescence
» Entrepreneurs Roundtable: How to Get Seed Funding
» More Naïve State of Human iPSCs?
» From Nature Biotechnology: SBIR grants wax
» Great Introduction of Allele Services at LIAI
» Buy Randox Laboratories products online NOW!
» SCRIPPS INSTITUTION OF OCEANOGRAPHY, UC SAN DIEGO Vendor Show
» Breakfast Vendor Show at UCSD and Free Lunch for a Lab Today
» SDEE Entrepreneurs Roundtable - How to Get Government Grants: The Insider’s View
» Biochip Array Technology – the future of Biomarker detection!
» NIH Announces SHIFT SBIR Grants to Help Academic Researchers Get Jobs in Biotech
» Breast Cancer Gene Patents Invalidated
» Rebuilding a windpipe with own stemcells
» Wnt/b-Catenin important for stem cells responsible for leukemia, but not needed in normal hematopoietic stem cells (HSC).
» Randox maternal screening control sera - Confidence when it’s needed most
» Blood vessels may be a new niche for stem cells
» Three types of skin cells can all come from one type of stem cells in the follicles
» New Randox Life Science Website up and running!
» MicroRNAs: From Decay to Decoy, and beyond
» News Release from Randox--NEW Liquid quality control sera available now
» iPS patent issues in the spotlight
» Analyzing miRNA, microarray vs next-gen sequencing, our own perspectives
» Silicon Nanowires to Penetrate Cell Membrane for TransfectionSilicon Nanowires to Penetrate Cell Membrane for Transfection
» Two affinity peptides linked as high affinity binders as “Synbody”
» Genome-wide association study (GWAS) of metabolic traits identified metabolically relevant enzymes or carriers.
» Nature Method's review on iPSCs and lists Allele Biotech as a supplier
» Drug based on RNAi targets tumor progression shows effects in bladder and liver cancer
» Reprogrammable mice created by a single insertion of polycistonic iPS factors
» New RNAi delivery technology demonstrates higher efficacy and decreased dosage requirements
» Baculovirus used to make flu vaccines in insect cells
» Magnetic nanoparticle tag used on detection antibody increase ELISA sensitvity
» Vitamine C stimulates reprogramming
» New dyes to make STED more widely used
» Injecting Stem Cells Into Brains
» Medical advances that sound like science fiction
» Making long RNA strands in warm water-mimicking reactions on primordial earth
» beta-globin control region and promoter-driven fluorescent protein used to monitor stem cell differentiation
» Using the right dose of ultrasound can increase tumor marker release
» How does Avastin compare to Herceptin in curing breast cancer?
» Real-Time PCR dye
» Knome launches first platform-agnostic human genome sequencing and analysis service for researchers
» Knockout screens using haploid human cells
» Lung cancer proteins may be cancer markers
» Sequence 100 human genomes in 10 days for under $10,000 per genome
» Rapid drugs of abuse screening from Randox
» BioTechnique: Recent papers advance GFP knowledge
» Your News Release Here
» Is US science the best in the world in the public eye?
» By Using Formaldehyde Crosslinking, Chromatins Found to Pack into Functional Compartments
» Dual Activation for Tighter Control of Induced Gene Expression
» Nobel Prize in Chemistry Goes to Researchers on Ribosome
» Nobel Prize in Physics on fiber optics and CCD digital sensor
» Intracellularly Expressed Camelid Single-Domain Antibody (VHH) Counteracts Cytotoxicity Seen in Agricultural Epidemics
» Breakfast at ACADIA Pharmaceuticals went very well
» Difference between hESCs and NSC-Derived Integration-Free iPSCs
» RNAi Has Been Found in Budding Yeast
» Stem cells found as origin for prostate cancer
» How to use photoconvertible fluorescent proteins to trace dynamic subcellular structures
» How many mutations you may have?
» Publication by Allele Scientists: A Tale of Twin Functions
» Sep 1st Vendor Show at Pac Hall
» RNAi machinery interacts with specialized chromatin component in regulating antisense RNAs
» iPSC generated by using a single reprogramming factor, Oct4…with limitations?
» Proof-of-Principle Validation that iPSCs are Functional Equivalent to ES Cells?
» Deoxyribozymes found to cut single-stranded DNA
» Making iPSC easier to create by suppressing p53
» Lab Visits: Please email us to schedule lab visits in your area.
» VHH from camelid antibodies can be found against integral membrane proteins


Other Articles:
UCSD Post-Doc Association 2nd Annual Vendor Fair on Wednesday, Sep 18th, 10am to 12, School of Medicine Liechtag Lawn (09.18.2012)
UCSD Vendor Show on Friday, June 15th, Medical School lawn (06.14.2012)
Going on now--Allele Biotech showing feeder-free, xeno-free, footprint-free human iPSCs at the Scripps annual vendor show (05.08.2012)
Allele presented the grant prize last Friday's Sanford-Burnham event (04.28.2012)
See Allele's Sales Managers for Deals at Scripps Tuesday 05/10 (05.09.2011)
Hello SDSU (08.03.2010)
Great Introduction of Allele Services at LIAI (06.11.2010)
SCRIPPS INSTITUTION OF OCEANOGRAPHY, UC SAN DIEGO Vendor Show (05.18.2010)
Breakfast Vendor Show at UCSD and Free Lunch for a Lab Today (05.05.2010)
Nice meeting you at BSB today's vendor show (04.21.2010)



 
  ::| Events
January 2018  
Su Mo Tu We Th Fr Sa
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
 
  News in Pictures

High quality histologic services are crucial for determining study outcomes. http://www.allelebiotech.com/histology/
::| Hot News
Grants and general administrator for the Scintillon Institute.
Positions available at Oxbridge Biotech Roundtable (OBR) San Diego
UCSD Vendor Show on Friday, June 15th, Medical School lawn
Going on now--Allele Biotech showing feeder-free, xeno-free, footprint-free human iPSCs at the Scripps annual vendor show
Allele presented the grant prize last Friday's Sanford-Burnham event